Hetalox
PrivateLast Round
Grant
Feb 18, 2025
Total Funding Raised
$110,000
Company Overview
Hetalox is a medical technology company that provides a SaaS platform with artificial intelligence (AI) solutions for the advanced assessment and analysis of brain MRI studies.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hetalox Comps
Public and private peers based on sector, stage, and business model.
Hetalox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 18, 2025 |
Hetalox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 24Ventures VC | Grant |
| European Funds for a Modern Economy | Grant |
| Polish Agency for Enterprise Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2025
Grew 100% QoQ, from 3 to 6 employees.
- Feb 18, 2025
$110K grant round led by Polish Agency for Enterprise Development.
Hetalox Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hetalox's valuation, stock price, and market status.
